°øÁö»çÇ×

³»¿ëºÐ·ù Á¤±â¼¼¹Ì³ª
°Ô½ÃÀÚ PGRC ()
Á¦¸ñ [PGRC]±Ý¿ä Àú³ÎŬ·´ °øÁö(2017/2/10)
ÂüÁ¶URL  ÂüÁ¶URL Á¤º¸¾øÀ½.
ÂüÁ¶ÆÄÀÏ  ÆÄÀϾøÀ½
³»¿ë
¾à¹°À¯Àüü¿¬±¸¼¾ÅÍ¿¡¼­´Â ´ÙÀ½°ú °°Àº ³»¿ëÀ¸·Î ¼¼¹Ì³ª¸¦ °³ÃÖÇÕ´Ï´Ù. °ü½É ÀÖ´Â ±³¼ö´Ô, ¿¬±¸¿ø ¿©·¯ºÐÀÇ Àû±ØÀûÀÎ Âü¿© ¹Ù¶ø´Ï´Ù.

1) Àú³ÎŬ·´ ¿¬Á¦
-Pharmacokinetics and Differential Regulation of Cytochrome P450 Enzymes in Type 1 Allergic Mice
- Inhibition of Intestinal OATP2B1 by the Calcium Receptor Antagonist Ronacaleret Results in a Significant Drug-Drug Interaction by Causing a 2-Fold Decrease in Exposure of Rosuvastatin

2) Àú³ÎŬ·´ ¿¬ÀÚ
-  Ç㿹¶û / ±è³ªÀ² Á¶¼±¾Æ Á¶¹®ÁÖ
-  ÀÌÀ±Àç / Á¤ÇýÀº ¹ÚÁ¤¼ø ±è¿ì¿µ

3) ÀÏ ½Ã : 2017³â 2 ¿ù 10 ÀÏ (±Ý) ¿ÀÈÄ 4½Ã ~ 5½Ã